Promising Late-Stage Drugs Signal A New Treatment Era Delveinsight. The generalized myasthenia gravis treatment pipeline ...

Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing ...

Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript April 1, 2026 Operator: Good afternoon, and welcome to today’s earnings call for Omeros Corporation. [Operator Instructions] Please be ...

The mechanics of the onset of cancer or neurodegenerative disorders like Alzheimer's disease or ALS remain a mystery.

Novartis announced final two-year results from the phase III APPLAUSE-IgAN study of Fabhalta (iptacopan) in IgA nephropathy (IgAN). Fabhalta demonstrated a statistically significant, clinically ...

Instead, a mental health startup shut down and open-sourced its tech.

Vitiligo is often noticed before it is understood. White patches on the skin can draw attention, second glances or subtle ...

In global health, vaccines save lives, medicines cure disease, and surveillance stops outbreaks – and sanitation makes all of them work better. Far from being an “either-or” alternative to vaccines or ...

Overall, 88% of respondents reported awareness of at least one CT. The most frequently identified therapies were massage ...

The field of brain-computer interfaces is moving away from mind-controlled computer cursors to restoring speech.

Newer FDA-approved treatments for myasthenia gravis (MG) include FcRn blockers and complement inhibitors, which offer ...